Skip to content
Trial Eligibility
Menu

Observational Pharmaco-Epidemiology Research & Analysis

NCT03813862

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Greater advances are needed in two separate but related areas in healthcare: 1) the Clinical Decision Support Systems that complement the EHR use in support of routine patient care, population management and disease management; and 2) the use of the point-of-care observational data from the provider-patient encounter that support realworld medical research and healthcare quality measure assessment. Real-world evaluations of treatments of chronic diseases in the context of comorbid conditions and special populations (minorities, women, mentally ill, and those with addiction) are limited.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Chronic Disease
  • HIV/AIDS
  • Liver Diseases
  • Inflammatory Bowel Diseases
  • Cardiovascular Diseases
  • Rheumatic Diseases
  • Neurodegenerative Diseases

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
0 years and older
Sex
All
Healthy volunteers
Accepted
Sponsor
Epividian
Last updated on ClinicalTrials.gov
September 11, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

North Carolina · 1

  • Epividian · Durham, NC

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.